glp-1 law firm Agenda What You Need to Know
Description
PubMed Kateel R et al
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderatetosevere chronic kidney disease (AWARD7): a multicentre, openlabel, randomised trial
Calorie cycling and refeed days Rather than eating a consistent caloric deficit every day, some people respond to periodic higher-calorie days
Personalized programs allow for dosage adjustments based on how your body is actually responding
